BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38167780)

  • 1. [Primary hyperoxaluria type 1-a rare hereditary metabolic disorder as cause of livedo racemosa].
    Linse KP; Enk A; Toberer F
    Dermatologie (Heidelb); 2024 Apr; 75(4):321-324. PubMed ID: 38167780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary oxalosis--an unusual cause of livedo reticularis.
    Winship IM; Saxe NP; Hugel H
    Clin Exp Dermatol; 1991 Sep; 16(5):367-70. PubMed ID: 1794192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary oxalosis and livedo reticularis. Apropos of a case].
    Bodemer C; Flament F; Grunfeld JP; De Prost Y
    Ann Dermatol Venereol; 1989; 116(10):721-4. PubMed ID: 2610464
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxalosis in a Patient with Livedo Reticularis.
    Triki M; Ksentini M; Kallel R; Bahloul E; Jarraya F; Masmoudi A; Boudawara T
    Skinmed; 2017; 15(4):303-305. PubMed ID: 28859746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic policies on nephrolithiasis/nephrocalcinosis of possible genetic origin by Italian nephrologists: a survey by the Italian Society of Nephrology with an emphasis on primary hyperoxaluria.
    Ferraro PM; Caletti C; Capolongo G; Lombardi M; Scolari F; Vezzoli G; Vitale C; Gambaro G
    J Nephrol; 2023 Jul; 36(6):1605-1614. PubMed ID: 37358729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ENDOCRINE MANIFESTATIONS OF PRIMARY HYPEROXALURIA.
    Murad S; Eisenberg Y
    Endocr Pract; 2017 Dec; 23(12):1414-1424. PubMed ID: 29144803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Oxalobacter formigenes in subjects with primary hyperoxaluria Type 1 and end-stage renal disease: a Phase II study.
    Hoppe B; Pellikka PA; Dehmel B; Banos A; Lindner E; Herberg U
    Nephrol Dial Transplant; 2021 Jul; 36(8):1464-1473. PubMed ID: 32810261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary hyperoxaluria: report of a patient with livedo reticularis and digital infarcts.
    Marconi V; Mofid MZ; McCall C; Eckman I; Nousari HC
    J Am Acad Dermatol; 2002 Feb; 46(2 Suppl Case Reports):S16-8. PubMed ID: 11807460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary hyperoxaluria: simultaneous combined liver and kidney transplantation from a living related donor.
    Astarcioglu I; Karademir S; Gülay H; Bora S; Astarcioglu H; Kavukcu S; Türkmen M; Soylu A
    Liver Transpl; 2003 Apr; 9(4):433-6. PubMed ID: 12682898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary hyperoxaluria type 1 in children: clinical and laboratory manifestations and outcome.
    Wannous H
    Pediatr Nephrol; 2023 Aug; 38(8):2643-2648. PubMed ID: 36917293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical features of primary hyperoxaluria in end-stage renal disease.
    Absy MM
    Am J Nephrol; 1991; 11(4):301-4. PubMed ID: 1799188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxalosis involving the skin: case report and literature review.
    Blackmon JA; Jeffy BG; Malone JC; Knable AL
    Arch Dermatol; 2011 Nov; 147(11):1302-5. PubMed ID: 21768445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent cutaneous manifestations of hyperoxaluria after combined hepatorenal transplantation.
    Rubenstein MC; Martinelli PT; Bayer-Garner IB; Klebuc MJ; Curry JL; Hsu S
    Dermatol Online J; 2004 Jul; 10(1):10. PubMed ID: 15347492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous Oxalosis Due to Primary Hyperoxaluria.
    Ly S; Rick J; Goff R; David BA; Kincannon J; Shalin S
    Am J Dermatopathol; 2022 Dec; 44(12):981-983. PubMed ID: 36395453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery From Dialysis in Patients With Primary Hyperoxaluria Type 1 Treated With Pyridoxine: A Report of 3 Cases.
    Lorenz EC; Lieske JC; Seide BM; Olson JB; Mehta R; Milliner DS
    Am J Kidney Dis; 2021 May; 77(5):816-819. PubMed ID: 32891627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma oxalate levels in primary hyperoxaluria type I show significant intra-individual variation and do not correlate with kidney function.
    Hillebrand P; Hoppe B
    Pediatr Nephrol; 2020 Jul; 35(7):1227-1233. PubMed ID: 32274573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxalate kinetics and reversal of the complications after orthotopic liver transplantation in a patient with primary hyperoxalosis type 1 awaiting renal transplantation.
    Bastani B; Mistry BM; Nahass GT; Joh J; Dundoo G; Solomon H
    Am J Nephrol; 1999; 19(1):64-9. PubMed ID: 10085453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined liver-kidney transplantation in primary hyperoxaluria type 1.
    Cochat P; Gaulier JM; Koch Nogueira PC; Feber J; Jamieson NV; Rolland MO; Divry P; Bozon D; Dubourg L
    Eur J Pediatr; 1999 Dec; 158 Suppl 2():S75-80. PubMed ID: 10603104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxalosis and livedo reticularis.
    Jorquera-Barquero E; Súarez-Marrero MC; Fernández Girón F; Borrero Martín JJ
    Actas Dermosifiliogr; 2013 Nov; 104(9):815-8. PubMed ID: 23103120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing characteristics of pediatric patients with primary hyperoxaluria type 1 in PEDSnet.
    Tasian GE; Dickinson K; Park G; Marchesani N; Mittal A; Cheng N; Ching CB; Chu DI; Walton R; Yonekawa K; Gluck C; Muneeruddin S; Kan KM; DeFoor W; Rove K; Forrest CB
    J Pediatr Urol; 2024 Feb; 20(1):88.e1-88.e9. PubMed ID: 37848358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.